Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Charles M. Beasley"'
Publikováno v:
Aptitude, Learning, and Instruction ISBN: 9781003163145
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d3571b7bbf78319130f3b3812c5f074
https://doi.org/10.4324/9781003163145-21
https://doi.org/10.4324/9781003163145-21
Autor:
Brenda J. Crowe, Paul S. Horn, Charles M. Beasley, Rebeka Tabbey, Robert A. Dean, Lieling Wu, Mary E. Nilsson, Ryan T. Hietpas
Publikováno v:
Therapeutic Innovation & Regulatory Science. 51:683-737
Reference limits used in clinical medicine to screen and manage patients are typically developed nonparametrically using reference values from a limited number of healthy subjects using a 95th percentile reference interval. We have evaluated alternat
Autor:
Mustafa M. Tümüklü, Mevhibe N. Tümüklü, Herbert Y. Meltzer, Charles M. Beasley, Vladislav Nesterenko, Karu Jayathilake
Publikováno v:
Journal of clinical psychopharmacology. 39(2)
PURPOSE/BACKGROUND Prolonged ventricular repolarization, measured by heart rate-corrected QT interval (QTc) prolongation, might be a biomarker for risk of torsade de pointes (TdP) and sudden cardiac death. However, the predictive value of QTc has bee
Autor:
Lieling Wu, Brenda J. Crowe, Rebeka Tabbey, Robert A. Dean, Paul S. Horn, Ryan T. Hietpas, Mary E. Nilsson, Charles M. Beasley
The objective of this research was to compute reference limits using reference values from patients entering pharmaceutical development clinical trials by the nonparametric method and the robust method of Horn and Pesce, with and without outlier excl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0bb60637f5b4d17247fa29240ade399
Autor:
Malcolm I. Mitchell, John H. April, Prajakti A. Kothare, Charles M. Beasley, Ling Jin, Harry Haber, Lynnette Kauffman, Corina Loghin, Albert J. Allen
Publikováno v:
British Journal of Clinical Pharmacology. 75:549-564
Aim The effects of atomoxetine (20 and 60 mg twice daily), 400 mg moxifloxacin and placebo on QTc in 131 healthy CYP2D6 poor metabolizer males were compared.
Autor:
S. Stanley Young, Charles M. Beasley, Jessie Q. Xia, Charles Benson, Harry Haber, Corina Loghin, Malcolm I. Mitchell
Publikováno v:
Pacing and Clinical Electrophysiology. 34:1116-1127
Background: Many thorough QT (TQT) studies use a baseline day and double delta analysis to account for potential diurnal variation in QTc. However, little is known about systematic changes in the QTc across contiguous days when normal volunteers are
Autor:
Sharon-Lise T. Normand, Herbert Y. Meltzer, Roger E. Meyer, David Shaffer, Madhukar H. Trivedi, Gregory K. Brown, Neal D. Ryan, Carl Salzman, Karl Broich, J. John Mann, Kelly Posner, Maria A. Oquendo, Frederick K. Goodwin, Gustavo Turecki, Charles M. Beasley, Annette L. Beautrais, Jeffrey A. Bridge, Larry Alphs, Wayne K. Goodman, David V. Sheehan, Dennis A. Revicki, Barbara Stanley, Eric A. Youngstrom, John F. Greden, Paula J. Clayton
Publikováno v:
The Journal of Clinical Psychiatry. 71:1040-1046
OBJECTIVE: To address issues concerning potential treatment-emergent "suicidality," a consensus conference was convened March 23-24, 2009. PARTICIPANTS: This gathering of participants from academia, government, and industry brought together experts i
Publikováno v:
Psychological Medicine. 37:1585-1593
BackgroundThe association between treatment-emergent suicidality as an adverse event and fluoxetine treatment was examined using a fluoxetine double-blind placebo-controlled database of clinical trials for indications other than major depressive diso
Autor:
Jay D. Amsterdam, Roy H. Perlis, Maurizio Fava, Frederic M. Quitkin, Jerrold F. Rosenbaum, Cristina Cusin, Frederick W. Reimherr, Charles M. Beasley
Publikováno v:
The Journal of Clinical Psychiatry. 68:52-57
Background A subset of patients experience worsening of depressed mood after beginning antidepressant treatment, which could represent the natural history of the illness or a treatment-related effect. While patterns of response have been examined as
Autor:
Roy H. Perlis, Frederick M. Quitkin, Deborah L. Shear, Jerrold F. Rosenbaum, Charles M. Beasley, Roy N. Tamura, James D. Wines, Cristina Cusin, Maurizio Fava, Robert E. Strong, Jay D. Amsterdam
Publikováno v:
Psychotherapy and Psychosomatics. 76:40-46
Background: Some reports suggest that a subset of depressed patients may experience suicidality – that is increase or emergence of suicidal ideation (SI) or behavior – after initiation of an antidepressant. The time course and clinical correlates